In previous studies, the decrease of serum FGF21 was also observed under conditions of severe NAFLD and autoimmune diabetes, which resulted from impaired cell function caused by lipotoxicity, hepatic inflammation or autoimmune antibodies24,25. This evidence concerns the gene FGF21 and metabolic dysfunction-associated steatotic liver disease.